8-K: Specificity, Inc. Restates Financials Due to Error

Specificity, Inc. announced a restatement of its 2025 financial statements due to errors in expense and revenue recognition, impacting its 2026 quarterly report.

Summary

• Specificity, Inc. has identified errors in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
• These errors led to a delay in filing the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
• The errors stemmed from a failure to obtain and review bank and credit card statements for accounts opened in mid-December 2025.
• Preliminary analysis indicates an approximate understatement of expenses by $83,422 and revenues by $2,500.
• There was also an understatement of liabilities by $121,122, an overstatement of additional paid-in capital by $40,000, and an understatement of cash by $202.
• The company believes these errors are isolated to the opening of accounts in mid-December 2025 and do not affect 2025 quarterly operating results.
• Specificity, Inc. is preparing an amended Form 10-K/A for the year ended December 31, 2025, and completing its Form 10-Q for the quarter ended March 31, 2026.
• Both reports will be filed as soon as practical, following discussion with the independent registered public accounting firm, CM3 Advisory.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative development due to the financial restatement and delayed filings, indicating potential internal control issues, though the prompt corrective action mitigates some of the concern.

Positives

• The company proactively identified and is correcting errors in its financial statements.
• The errors are believed to be isolated to a specific period (mid-December 2025) and do not impact prior quarterly operating results.
• Management has engaged with the independent registered public accounting firm to ensure accuracy.
• The company is committed to filing amended and completed financial reports promptly.

Negatives

• Errors were found in the previously issued financial statements for the fiscal year ended December 31, 2025.
• The company experienced a delay in filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
• There were material misstatements identified, including understatements of expenses and revenues, and misstatements in liabilities, paid-in capital, and cash.
• The need for restatement and amendment indicates a lapse in internal controls or review processes.

Risks

• Potential for further errors to be discovered during the review process by CM3 Advisory.
• Risk of increased scrutiny from regulators and investors due to the restatement.
• Possible negative impact on investor confidence and stock price.
• Delays in filing financial reports can lead to potential non-compliance issues with exchange listing requirements.

Future Outlook

The company is concurrently preparing an amendment on Form 10-K/A for the year ended December 31, 2025, and completing its quarterly report on Form 10-Q for the three months ended March 31, 2026, intending to file both as soon as practical.

Management Comments

• The underlying error was due to an inadvertent failure by management to obtain and review certain bank and credit card statements associated with accounts opened in mid-December 2025.
• The Company believes that these errors have no effect upon the operating results for the quarterly reporting periods during 2025.
• The Company intends to file both financial reports as soon as practical.

Industry Context

StockSavvy.ai notes that financial restatements, while concerning, are not uncommon. However, the nature of the error (failure to review bank statements) suggests potential weaknesses in internal controls that warrant investor attention. The promptness of the correction and engagement with auditors are positive signs.

Stakeholder Impact

• Shareholders: Potential decrease in confidence due to financial reporting errors and delays; potential impact on stock price.
• Creditors: May require assurance regarding the accuracy of financial statements impacting debt covenants.
• Regulators (SEC): Increased scrutiny on the company's financial reporting and internal controls.

Next Steps

• File an amended Form 10-K/A for the year ended December 31, 2025.
• Complete and file the Quarterly Report on Form 10-Q for the three months ended March 31, 2026.
• Undergo review of restatement amounts by CM3 Advisory.

Key Dates

Recommendation

The financial restatement and delay in filings introduce uncertainty and suggest potential internal control weaknesses. While the company is taking corrective actions, the impact on investor confidence and future reporting accuracy remains to be seen. A 'hold' recommendation allows investors to await the refiled financial statements and further clarity on the company's control environment before making a more definitive investment decision.

Keywords

8-K Filing, Financial Restatement, Form 10-K, Form 10-Q, SEC Filing, Accounting Errors, Specificity, Inc., Financial Reporting